Global Cell-Based Immunotherapy Market Size, Status and Forecast 2024-2031

Report ID: 921948 | Published Date: Oct 2024 | No. of Page: 118 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell-Based Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Autologous Cellular Immunotherapy
        1.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
        1.2.4 Dendritic Cell-based Vaccine Therapy
    1.3 Market by Application
        1.3.1 Global Cell-Based Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cell-Based Immunotherapy Market Perspective (2016-2027)
    2.2 Cell-Based Immunotherapy Growth Trends by Regions
        2.2.1 Cell-Based Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cell-Based Immunotherapy Historic Market Share by Regions (2016-2021)
        2.2.3 Cell-Based Immunotherapy Forecasted Market Size by Regions (2022-2027)
    2.3 Cell-Based Immunotherapy Industry Dynamic
        2.3.1 Cell-Based Immunotherapy Market Trends
        2.3.2 Cell-Based Immunotherapy Market Drivers
        2.3.3 Cell-Based Immunotherapy Market Challenges
        2.3.4 Cell-Based Immunotherapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cell-Based Immunotherapy Players by Revenue
        3.1.1 Global Top Cell-Based Immunotherapy Players by Revenue (2016-2021)
        3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2016-2021)
    3.2 Global Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cell-Based Immunotherapy Revenue
    3.4 Global Cell-Based Immunotherapy Market Concentration Ratio
        3.4.1 Global Cell-Based Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Immunotherapy Revenue in 2020
    3.5 Cell-Based Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Cell-Based Immunotherapy Product Solution and Service
    3.7 Date of Enter into Cell-Based Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cell-Based Immunotherapy Breakdown Data by Type
    4.1 Global Cell-Based Immunotherapy Historic Market Size by Type (2016-2021)
    4.2 Global Cell-Based Immunotherapy Forecasted Market Size by Type (2022-2027)

5 Cell-Based Immunotherapy Breakdown Data by Application
    5.1 Global Cell-Based Immunotherapy Historic Market Size by Application (2016-2021)
    5.2 Global Cell-Based Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cell-Based Immunotherapy Market Size (2016-2027)
    6.2 North America Cell-Based Immunotherapy Market Size by Type
        6.2.1 North America Cell-Based Immunotherapy Market Size by Type (2016-2021)
        6.2.2 North America Cell-Based Immunotherapy Market Size by Type (2022-2027)
        6.2.3 North America Cell-Based Immunotherapy Market Size by Type (2016-2027)
    6.3 North America Cell-Based Immunotherapy Market Size by Application
        6.3.1 North America Cell-Based Immunotherapy Market Size by Application (2016-2021)
        6.3.2 North America Cell-Based Immunotherapy Market Size by Application (2022-2027)
        6.3.3 North America Cell-Based Immunotherapy Market Size by Application (2016-2027)
    6.4 North America Cell-Based Immunotherapy Market Size by Country
        6.4.1 North America Cell-Based Immunotherapy Market Size by Country (2016-2021)
        6.4.2 North America Cell-Based Immunotherapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cell-Based Immunotherapy Market Size (2016-2027)
    7.2 Europe Cell-Based Immunotherapy Market Size by Type
        7.2.1 Europe Cell-Based Immunotherapy Market Size by Type (2016-2021)
        7.2.2 Europe Cell-Based Immunotherapy Market Size by Type (2022-2027)
        7.2.3 Europe Cell-Based Immunotherapy Market Size by Type (2016-2027)
    7.3 Europe Cell-Based Immunotherapy Market Size by Application
        7.3.1 Europe Cell-Based Immunotherapy Market Size by Application (2016-2021)
        7.3.2 Europe Cell-Based Immunotherapy Market Size by Application (2022-2027)
        7.3.3 Europe Cell-Based Immunotherapy Market Size by Application (2016-2027)
    7.4 Europe Cell-Based Immunotherapy Market Size by Country
        7.4.1 Europe Cell-Based Immunotherapy Market Size by Country (2016-2021)
        7.4.2 Europe Cell-Based Immunotherapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cell-Based Immunotherapy Market Size (2016-2027)
    8.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Type
        8.2.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Application
        8.3.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cell-Based Immunotherapy Market Size by Region
        8.4.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cell-Based Immunotherapy Market Size (2016-2027)
    9.2 Latin America Cell-Based Immunotherapy Market Size by Type
        9.2.1 Latin America Cell-Based Immunotherapy Market Size by Type (2016-2021)
        9.2.2 Latin America Cell-Based Immunotherapy Market Size by Type (2022-2027)
        9.2.3 Latin America Cell-Based Immunotherapy Market Size by Type (2016-2027)
    9.3 Latin America Cell-Based Immunotherapy Market Size by Application
        9.3.1 Latin America Cell-Based Immunotherapy Market Size by Application (2016-2021)
        9.3.2 Latin America Cell-Based Immunotherapy Market Size by Application (2022-2027)
        9.3.3 Latin America Cell-Based Immunotherapy Market Size by Application (2016-2027)
    9.4 Latin America Cell-Based Immunotherapy Market Size by Country
        9.4.1 Latin America Cell-Based Immunotherapy Market Size by Country (2016-2021)
        9.4.2 Latin America Cell-Based Immunotherapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cell-Based Immunotherapy Market Size (2016-2027)
    10.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type
        10.2.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application
        10.3.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cell-Based Immunotherapy Market Size by Country
        10.4.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Cell-Based Immunotherapy Introduction
        11.1.4 Novartis Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.1.5 Novartis Recent Development
    11.2 Gilead Sciences
        11.2.1 Gilead Sciences Company Details
        11.2.2 Gilead Sciences Business Overview
        11.2.3 Gilead Sciences Cell-Based Immunotherapy Introduction
        11.2.4 Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.2.5 Gilead Sciences Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Cell-Based Immunotherapy Introduction
        11.3.4 AbbVie Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.3.5 AbbVie Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Amgen
        11.5.1 Amgen Company Details
        11.5.2 Amgen Business Overview
        11.5.3 Amgen Cell-Based Immunotherapy Introduction
        11.5.4 Amgen Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.5.5 Amgen Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Cell-Based Immunotherapy Introduction
        11.6.4 AstraZeneca Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.6.5 AstraZeneca Recent Development
    11.7 Biogen
        11.7.1 Biogen Company Details
        11.7.2 Biogen Business Overview
        11.7.3 Biogen Cell-Based Immunotherapy Introduction
        11.7.4 Biogen Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.7.5 Biogen Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Details
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Introduction
        11.8.4 Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Eli Lilly and Company
        11.9.1 Eli Lilly and Company Company Details
        11.9.2 Eli Lilly and Company Business Overview
        11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Introduction
        11.9.4 Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.9.5 Eli Lilly and Company Recent Development
    11.10 GSK
        11.10.1 GSK Company Details
        11.10.2 GSK Business Overview
        11.10.3 GSK Cell-Based Immunotherapy Introduction
        11.10.4 GSK Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.10.5 GSK Recent Development
    11.11 Pfizer
        11.11.1 Pfizer Company Details
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer Cell-Based Immunotherapy Introduction
        11.11.4 Pfizer Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.11.5 Pfizer Recent Development
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche Cell-Based Immunotherapy Introduction
        11.12.4 Roche Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.12.5 Roche Recent Development
    11.13 Takara Bio
        11.13.1 Takara Bio Company Details
        11.13.2 Takara Bio Business Overview
        11.13.3 Takara Bio Cell-Based Immunotherapy Introduction
        11.13.4 Takara Bio Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.13.5 Takara Bio Recent Development
    11.14 Bausch Health
        11.14.1 Bausch Health Company Details
        11.14.2 Bausch Health Business Overview
        11.14.3 Bausch Health Cell-Based Immunotherapy Introduction
        11.14.4 Bausch Health Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.14.5 Bausch Health Recent Development
    11.15 Apac Biotech
        11.15.1 Apac Biotech Company Details
        11.15.2 Apac Biotech Business Overview
        11.15.3 Apac Biotech Cell-Based Immunotherapy Introduction
        11.15.4 Apac Biotech Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.15.5 Apac Biotech Recent Development
    11.16 Dendreon Pharmaceuticals (SanPower)
        11.16.1 Dendreon Pharmaceuticals (SanPower) Company Details
        11.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
        11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Introduction
        11.16.4 Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.16.5 Dendreon Pharmaceuticals (SanPower) Recent Development
    11.17 JW CreaGene
        11.17.1 JW CreaGene Company Details
        11.17.2 JW CreaGene Business Overview
        11.17.3 JW CreaGene Cell-Based Immunotherapy Introduction
        11.17.4 JW CreaGene Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.17.5 JW CreaGene Recent Development
    11.18 Green Cross Corp
        11.18.1 Green Cross Corp Company Details
        11.18.2 Green Cross Corp Business Overview
        11.18.3 Green Cross Corp Cell-Based Immunotherapy Introduction
        11.18.4 Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2016-2021)
        11.18.5 Green Cross Corp Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cell-Based Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Autologous Cellular Immunotherapy
    Table 3. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Table 4. Key Players of Dendritic Cell-based Vaccine Therapy
    Table 5. Global Cell-Based Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cell-Based Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Cell-Based Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Cell-Based Immunotherapy Market Share by Regions (2016-2021)
    Table 9. Global Cell-Based Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Cell-Based Immunotherapy Market Share by Regions (2022-2027)
    Table 11. Cell-Based Immunotherapy Market Trends
    Table 12. Cell-Based Immunotherapy Market Drivers
    Table 13. Cell-Based Immunotherapy Market Challenges
    Table 14. Cell-Based Immunotherapy Market Restraints
    Table 15. Global Cell-Based Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Cell-Based Immunotherapy Market Share by Players (2016-2021)
    Table 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Based Immunotherapy as of 2020)
    Table 18. Ranking of Global Top Cell-Based Immunotherapy Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Cell-Based Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cell-Based Immunotherapy Product Solution and Service
    Table 22. Date of Enter into Cell-Based Immunotherapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Cell-Based Immunotherapy Revenue Market Share by Type (2016-2021)
    Table 26. Global Cell-Based Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Cell-Based Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Cell-Based Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Cell-Based Immunotherapy Revenue Market Share by Application (2016-2021)
    Table 30. Global Cell-Based Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Cell-Based Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Novartis Company Details
    Table 63. Novartis Business Overview
    Table 64. Novartis Cell-Based Immunotherapy Product
    Table 65. Novartis Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 66. Novartis Recent Development
    Table 67. Gilead Sciences Company Details
    Table 68. Gilead Sciences Business Overview
    Table 69. Gilead Sciences Cell-Based Immunotherapy Product
    Table 70. Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 71. Gilead Sciences Recent Development
    Table 72. AbbVie Company Details
    Table 73. AbbVie Business Overview
    Table 74. AbbVie Cell-Based Immunotherapy Product
    Table 75. AbbVie Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 76. AbbVie Recent Development
    Table 77. Bristol-Myers Squibb Company Details
    Table 78. Bristol-Myers Squibb Business Overview
    Table 79. Bristol-Myers Squibb Cell-Based Immunotherapy Product
    Table 80. Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 81. Bristol-Myers Squibb Recent Development
    Table 82. Amgen Company Details
    Table 83. Amgen Business Overview
    Table 84. Amgen Cell-Based Immunotherapy Product
    Table 85. Amgen Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 86. Amgen Recent Development
    Table 87. AstraZeneca Company Details
    Table 88. AstraZeneca Business Overview
    Table 89. AstraZeneca Cell-Based Immunotherapy Product
    Table 90. AstraZeneca Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 91. AstraZeneca Recent Development
    Table 92. Biogen Company Details
    Table 93. Biogen Business Overview
    Table 94. Biogen Cell-Based Immunotherapy Product
    Table 95. Biogen Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 96. Biogen Recent Development
    Table 97. Boehringer Ingelheim Company Details
    Table 98. Boehringer Ingelheim Business Overview
    Table 99. Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 100. Boehringer Ingelheim Recent Development
    Table 101. Eli Lilly and Company Company Details
    Table 102. Eli Lilly and Company Business Overview
    Table 103. Eli Lilly and Company Cell-Based Immunotherapy Product
    Table 104. Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 105. Eli Lilly and Company Recent Development
    Table 106. GSK Company Details
    Table 107. GSK Business Overview
    Table 108. GSK Cell-Based Immunotherapy Product
    Table 109. GSK Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 110. GSK Recent Development
    Table 111. Pfizer Company Details
    Table 112. Pfizer Business Overview
    Table 113. Pfizer Cell-Based Immunotherapy Product
    Table 114. Pfizer Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 115. Pfizer Recent Development
    Table 116. Roche Company Details
    Table 117. Roche Business Overview
    Table 118. Roche Cell-Based Immunotherapy Product
    Table 119. Roche Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 120. Roche Recent Development
    Table 121. Takara Bio Company Details
    Table 122. Takara Bio Business Overview
    Table 123. Takara Bio Cell-Based Immunotherapy Product
    Table 124. Takara Bio Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 125. Takara Bio Recent Development
    Table 126. Bausch Health Company Details
    Table 127. Bausch Health Business Overview
    Table 128. Bausch Health Cell-Based Immunotherapy Product
    Table 129. Bausch Health Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 130. Bausch Health Recent Development
    Table 131. Apac Biotech Company Details
    Table 132. Apac Biotech Business Overview
    Table 133. Apac Biotech Cell-Based Immunotherapy Product
    Table 134. Apac Biotech Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 135. Apac Biotech Recent Development
    Table 136. Dendreon Pharmaceuticals (SanPower) Company Details
    Table 137. Dendreon Pharmaceuticals (SanPower) Business Overview
    Table 138. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product
    Table 139. Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 140. Dendreon Pharmaceuticals (SanPower) Recent Development
    Table 141. JW CreaGene Company Details
    Table 142. JW CreaGene Business Overview
    Table 143. JW CreaGene Cell-Based Immunotherapy Product
    Table 144. JW CreaGene Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 145. JW CreaGene Recent Development
    Table 146. Green Cross Corp Company Details
    Table 147. Green Cross Corp Business Overview
    Table 148. Green Cross Corp Cell-Based Immunotherapy Product
    Table 149. Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
    Table 150. Green Cross Corp Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell-Based Immunotherapy Market Share by Type: 2020 VS 2027
    Figure 2. Autologous Cellular Immunotherapy Features
    Figure 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Features
    Figure 4. Dendritic Cell-based Vaccine Therapy Features
    Figure 5. Global Cell-Based Immunotherapy Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Others Case Studies
    Figure 10. Cell-Based Immunotherapy Report Years Considered
    Figure 11. Global Cell-Based Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Cell-Based Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Cell-Based Immunotherapy Market Share by Regions: 2020 VS 2027
    Figure 14. Global Cell-Based Immunotherapy Market Share by Regions (2022-2027)
    Figure 15. Global Cell-Based Immunotherapy Market Share by Players in 2020
    Figure 16. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Based Immunotherapy as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2020
    Figure 18. Global Cell-Based Immunotherapy Revenue Market Share by Type (2016-2021)
    Figure 19. Global Cell-Based Immunotherapy Revenue Market Share by Type (2022-2027)
    Figure 20. North America Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Cell-Based Immunotherapy Market Share by Type (2016-2027)
    Figure 22. North America Cell-Based Immunotherapy Market Share by Application (2016-2027)
    Figure 23. North America Cell-Based Immunotherapy Market Share by Country (2016-2027)
    Figure 24. United States Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Cell-Based Immunotherapy Market Share by Type (2016-2027)
    Figure 28. Europe Cell-Based Immunotherapy Market Share by Application (2016-2027)
    Figure 29. Europe Cell-Based Immunotherapy Market Share by Country (2016-2027)
    Figure 30. Germany Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Cell-Based Immunotherapy Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Cell-Based Immunotherapy Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Cell-Based Immunotherapy Market Share by Region (2016-2027)
    Figure 40. China Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Cell-Based Immunotherapy Market Share by Type (2016-2027)
    Figure 48. Latin America Cell-Based Immunotherapy Market Share by Application (2016-2027)
    Figure 49. Latin America Cell-Based Immunotherapy Market Share by Country (2016-2027)
    Figure 50. Mexico Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Cell-Based Immunotherapy Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Cell-Based Immunotherapy Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Cell-Based Immunotherapy Market Share by Country (2016-2027)
    Figure 56. Turkey Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Novartis Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 60. Gilead Sciences Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 61. AbbVie Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 63. Amgen Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 64. AstraZeneca Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 65. Biogen Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 66. Boehringer Ingelheim Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 67. Eli Lilly and Company Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 68. GSK Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 69. Pfizer Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 70. Roche Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 71. Takara Bio Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 72. Bausch Health Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 73. Apac Biotech Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 74. Dendreon Pharmaceuticals (SanPower) Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 75. JW CreaGene Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 76. Green Cross Corp Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
Frequently Asked Questions
Cell-Based Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell-Based Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell-Based Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports